MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic
出版年份 2021 全文链接
标题
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic
作者
关键词
-
出版物
Future Oncology
Volume -, Issue -, Pages -
出版商
Future Medicine Ltd
发表日期
2021-01-11
DOI
10.2217/fon-2020-1048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
- (2020) Stephen T. Oh et al. Blood Advances
- The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review
- (2019) Mario Tiribelli et al. BONE MARROW TRANSPLANTATION
- Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients
- (2018) Maura Nicolosi et al. LEUKEMIA
- Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response
- (2018) Xueping Luo et al. Blood Cancer Journal
- Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
- (2017) Juan-Carlos Hernández-Boluda et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials
- (2017) Chad Gwaltney et al. LEUKEMIA RESEARCH
- Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
- (2016) A. A. Zahr et al. HAEMATOLOGICA
- Alleviating anemia and thrombocytopenia in myelofibrosis patients
- (2016) Francisco Cervantes et al. Expert Review of Hematology
- Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
- (2016) A. A. Zahr et al. HAEMATOLOGICA
- Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) A. M. Vannucchi et al. ANNALS OF ONCOLOGY
- Effect of Red Blood Cell Transfusion Dependence on the Natural History of Myeloproliferative Neoplasm-Associated Myelofibrosis
- (2015) Justyna Bartoszko et al. Clinical Lymphoma Myeloma & Leukemia
- Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation
- (2014) Jacqueline M. Langdon et al. AMERICAN JOURNAL OF HEMATOLOGY
- How I treat myelofibrosis
- (2014) F. Cervantes BLOOD
- Systemic Iron Homeostasis
- (2013) Tomas Ganz PHYSIOLOGICAL REVIEWS
- One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience
- (2012) Ayalew Tefferi et al. MAYO CLINIC PROCEEDINGS
- The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
- (2011) R. Scherber et al. BLOOD
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS
- (2010) C. Elena et al. HAEMATOLOGICA
- DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
- (2010) Naseema Gangat et al. JOURNAL OF CLINICAL ONCOLOGY
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
- (2009) F. Passamonti et al. BLOOD
- Iron overload and toxicity: the hidden risk of multiple blood transfusions
- (2009) A. Shander et al. VOX SANGUINIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started